Symbol
| PIM2
| contributors: mct - updated : 06-03-2015
|
HGNC name
| pim-2 oncogene
|
HGNC id
| 8987
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in multiple B-cell lymphoma types, associated with an aggressive clinical course | tumoral
|  
|  
| --over
|  
|
in Prostate cancer cell lines and tissues | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
PIM2 kinase inhibition is a rational approach in DLBCL treatment | cancer | hemopathy | | |
new target for multiple myeloma treatment | cancer | reproductive | breast | |
PIM2-USP27X-MYC signaling axis is a new potential target for breast cancer treatment |
| | | |
| compound Pim knockhout mice show a profound reduction of body size and non efficient proliferation of peripheral T lymphocytes |